Page 2 - Best Nasopharyngeal cancer doctors: TOP 50 doctors

1,100+ cancer treatments performed – Dr. Ozadli specializes in nasopharyngeal cancer at Valued Med Hub Hospitals as an Assistant Professor.

• 23 years of experience of experience in medical oncology
• Trained at Ankara Oncology Training and Research Hospital
• Expert in lung, esophageal, gastric, and breast cancers
• Active researcher with publications in oncology

1,100+ oncology procedures performed – Prof. Elke Jaeger is one of Germany's top oncologists according to Focus rating.

• Head of Oncology and Hematology at Nordwest Clinic
• 41 years of experience of experience in oncology
• Member of the European Organization for Research and Treatment of Cancer (EORTC) expert committee
• Specializes in sarcoma treatment

Dr. Yildiz has published 17+ research papers on neuroendocrine tumors and rare cancer cases, with a focus on nasopharyngeal cancer at Medipol Mega University Hospital.

• Specializes in neuroendocrine tumors and rare cancer presentations
• Published in Medical Oncology and other peer-reviewed journals
• Experienced in diagnosing and treating complex paraneoplastic syndromes
• Works at a leading university hospital with advanced oncology facilities

Prof. Köstler is a leading medical oncologist at Vienna's top-tier Wiener Privatklinik, specializing in advanced targeted and immunotherapy.

• Over 22 years of experience of experience as an oncologist and internist
• Focuses on breast and gynecologic malignancies
• Associated Professor at the Medical University of Vienna
• Publishes research on biomarker development and tumor biology
• Expert in designing personalized, systemic cancer therapy plans

Dr. Fox leads a certified cancer center in Solingen, specializing in head and neck cancers including nasopharyngeal cancer.

• Over 14 years of experience of experience in hematology and oncology
• Expert in molecular diagnostics and targeted therapies
• Actively researches new treatments for haemato-oncological diseases
• Member of American Association for Cancer Research

Professor Keil specializes in diagnostic and interventional radiology, applying advanced imaging techniques like MRI and CT at the Academic Hospital Solingen.

• Graduated with honors from Julius-Maximilians-Universität Würzburg
• Deepened expertise under renowned Professor Rolf W. Günther
• Leading doctor since 2010 in Diagnostic and Interventional Radiology
• Specializes in cross-sectional imaging and interventional radiology services

Specializes in medical oncology with extensive training at Akdeniz University – one of Turkey's leading medical schools.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at multiple university hospitals including Akdeniz University Hospital
• Member of the Turkish Medical Oncology Association

Dr. Ozden brings over a decade of specialized medical oncology experience to nasopharyngeal cancer cases. He trained at Istanbul University's prestigious Cerrahpaşa Faculty of Medicine.

• Completed medical oncology subspecialty at Kocaeli University
• Practiced internal medicine and oncology since 2004
• English-language medical education background
• Works at VM Medical Park Pendik Hospital

Assoc. Prof. Nail Paksoy specializes in nasopharyngeal cancer at Medipol Bahçelievler Hospital, bringing extensive oncology expertise.

• Board-certified in medical oncology by ESMO
• Fellowship-trained at Istanbul University Oncology Institute
• Participated in international clinical trials for advanced cancer treatments
• Published research on various oncology topics in peer-reviewed journals

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

49 years of experience specializing in virotherapy – Dr. Jaunalksne leads the Clinical Immunology Center at Pauls Stradins Clinical University Hospital.

• Graduate of Riga Medical Institute
• Internship in Internal Medicine
• Head of Clinical Immunology Center

Trained in radiation oncology at Marmara University, specializing in precise cancer treatment techniques.

• Specialization in radiation oncology completed in 2016
• Medical degree from Marmara University Faculty of Medicine
• Practices at Emsey Hospital